
The operator is opening new pharmaceutical centers in Europe and Africa and is preparing for vaccine distribution.
The global network of GxP-certified Kuehne+Nagel branches has expanded with new pharmaceutical centers in Brussels and Johannesburg. The new branches handle the distribution of vaccines and other pharmaceutical and medical products under controlled temperatures. Direct access from airport aprons to public asphalt roads minimizes the risk of temperature fluctuations and guarantees total stability for sensitive products during the logistics journey. Both facilities have dedicated zones for all sensitive cargo in cold storage rooms with temperature ranges from < -20°C, +2°C to +8°C, and +15°C to +25°C. Furthermore, they offer the possibility of temperature adjustment by adding dry ice for deep-frozen cargo service at -60°C.
In Brussels, the new logistics hub is located in the Brucargo center on the outskirts of Brussels Airport – the first airport in the world to receive the IATA CEIV Pharma certification. The Belgian Kuehne+Nagel facility has 15,546 sqm of warehouse space and is fully connected to the recently expanded warehouse in Geel, as well as to the pan-European K+N PharmaChain road network managed from Luxembourg.
In Johannesburg, South Africa, the expanded K+N PharmaChain airfreight facility meets all requirements for comprehensive handling of temperature-sensitive cargo. Services include: consolidation, warehousing, and distribution across Africa. The use of modern refrigerated dollies allows for loading pallets on both the lower and upper decks of the aircraft. Moving the cargo to the GxP cold storage rooms located within the facility does not expose it to temperature fluctuations.
– Currently produced medical products are usually more valuable, more sensitive to temperature, and have a number of additional requirements regarding storage and transport conditions, and their distribution capabilities worldwide are limited. By expanding its network of pharmaceutical centers, Kuehne+Nagel provides its pharmaceutical and medical industry customers with the execution of demanding services, full supply chain visibility, and guarantees total regulatory compliance. Thanks to this, they can focus on the health and well-being of their patients, which is what matters most – said Yngve Ruud, member of the Management Board of Kuehne+Nagel.
Source: Kuehne+Nagel








